The dataset connects claims, labs and EHR, including physician notes to analyse: Who meets drug label or payer criteria based on actual BMI and comorbidities How titration and dosing progress in real-world care What metabolic outcomes patients achieve over time Which safety signals, such as liver or renal changes, emerge across populations Why patients discontinue or switch treatments, as documented in notes See real-world GLP-1 evidence in action Register for our webinar where we dive deeper into GLP-1 real-world evidence
Potential Research Domains and Implications Given the multifaceted properties of GHK-Cu, the peptide presents several promising research directions: Dermal and Mucosal Regeneration Research Research indicates GHK-Cu may support dermal repair, keratinocyte and fibroblast migration and proliferation, thickness of dermal layers, and reduction of matrix-damage markers in cellular aging models
Both Tirzepatide and Semaglutide produce weight loss that reverses substantially when medication stops
C., Liu, L., Pang, K
This framing raises important questions for fitness professionals, who are often asked to comment on or adapt training for clients using these medications